Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $34,722 | 2,473 | 99.5% |
| Education | $158.80 | 9 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $3,854 | 354 | $0 (2024) |
| Boston Scientific Corporation | $3,391 | 61 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,724 | 115 | $0 (2024) |
| PFIZER INC. | $2,113 | 156 | $0 (2024) |
| ABBVIE INC. | $2,020 | 123 | $0 (2024) |
| Amgen Inc. | $1,539 | 116 | $0 (2024) |
| Daiichi Sankyo Inc. | $1,512 | 194 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,400 | 77 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,349 | 116 | $0 (2024) |
| Astellas Pharma US Inc | $1,116 | 76 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,891 | 260 | AstraZeneca Pharmaceuticals LP ($683.70) |
| 2023 | $4,527 | 261 | ABBVIE INC. ($590.44) |
| 2022 | $5,278 | 328 | Boston Scientific Corporation ($736.00) |
| 2021 | $4,336 | 328 | AbbVie Inc. ($486.29) |
| 2020 | $3,309 | 253 | Boston Scientific Corporation ($532.87) |
| 2019 | $3,807 | 327 | Novo Nordisk Inc ($576.69) |
| 2018 | $4,175 | 343 | Novo Nordisk Inc ($602.07) |
| 2017 | $4,558 | 382 | BOSTON SCIENTIFIC CORPORATION ($573.46) |
All Payment Transactions
2,482 individual payment records from CMS Open Payments — Page 1 of 100
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $12.03 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Neuroscience | ||||||
| 12/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Inflammation | ||||||
| 12/16/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: Oncology | ||||||
| 12/16/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/10/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardio-renal | ||||||
| 12/09/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: PSYCHIATRY | ||||||
| 12/04/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/26/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.35 | General |
| Category: Diabetes | ||||||
| 11/26/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.74 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $3.81 | General |
| Category: NEUROSCIENCE | ||||||
| 11/21/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Diabetes Care | ||||||
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.73 | General |
| Category: Cardio-renal | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.75 | General |
| Category: Endocrinology | ||||||
| 11/19/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $20.77 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $10.25 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $9.61 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.82 | General |
| Category: Gastroenterology | ||||||
| 11/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Bone Health | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.78 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 2,405 | 3,983 | $736,918 | $238,895 |
| 2022 | 25 | 2,451 | 4,293 | $634,570 | $225,178 |
| 2021 | 24 | 2,532 | 5,035 | $527,283 | $268,524 |
| 2020 | 23 | 1,971 | 5,707 | $556,280 | $193,007 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 499 | 855 | $258,930 | $66,885 | 25.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 265 | 265 | $76,270 | $33,124 | 43.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 76 | 523 | $81,573 | $28,638 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 306 | 518 | $105,930 | $27,791 | 26.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 63 | 63 | $20,330 | $17,457 | 85.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 206 | 209 | $24,186 | $14,164 | 58.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 279 | 279 | $53,119 | $13,947 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 65 | 77 | $32,621 | $9,978 | 30.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 230 | 233 | $12,770 | $6,803 | 53.3% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 47 | 48 | $13,990 | $4,988 | 35.7% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 43 | 86 | $17,545 | $4,280 | 24.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 77 | 77 | $4,030 | $2,238 | 55.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 32 | 41 | $6,591 | $2,141 | 32.5% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 14 | 14 | $1,708 | $1,674 | 98.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 27 | 27 | $8,503 | $1,447 | 17.0% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 11 | 12 | $1,726 | $624.04 | 36.2% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 16 | 61 | $4,672 | $581.80 | 12.5% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 16 | 17 | $1,876 | $523.26 | 27.9% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 24 | 24 | $2,740 | $480.18 | 17.5% |
| 90715 | Diphtheria, tetanus, and acellular pertussis vaccine (7 years or older) | Office | 2023 | 17 | 17 | $1,173 | $427.34 | 36.4% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 49 | 492 | $3,175 | $355.92 | 11.2% |
| 90471 | Administration of vaccine | Office | 2023 | 19 | 19 | $965.00 | $247.20 | 25.6% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 24 | 26 | $2,496 | $100.59 | 4.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 418 | 836 | $152,855 | $48,135 | 31.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 389 | 525 | $141,897 | $39,153 | 27.6% |
About Dr. Matthew Haley, DO
Dr. Matthew Haley, DO is a Family Medicine healthcare provider based in Carbondale, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1851384085.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Haley, DO has received a total of $34,881 in payments from pharmaceutical and medical device companies, with $4,891 received in 2024. These payments were reported across 2,482 transactions from 75 companies. The most common payment nature is "Food and Beverage" ($34,722).
As a Medicare-enrolled provider, Haley has provided services to 9,359 Medicare beneficiaries, totaling 19,018 services with total Medicare billing of $925,605. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Carbondale, PA
- Active Since 08/23/2005
- Last Updated 08/21/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1851384085
Products in Payments
- FARXIGA (Drug) $2,097
- Ozempic (Drug) $1,910
- XIFAXAN (Drug) $1,336
- VRAYLAR (Drug) $1,090
- INJECTAFER (Drug) $924.75
- UBRELVY (Drug) $852.98
- CHANTIX (Drug) $796.56
- Kerendia (Drug) $785.06
- ELIQUIS (Drug) $767.24
- TRELEGY ELLIPTA (Drug) $758.14
- Vascepa (Drug) $740.19
- REXULTI (Drug) $683.73
- Otezla (Drug) $646.37
- Livalo (Drug) $573.99
- ENTRESTO (Drug) $552.94
- Rybelsus (Drug) $539.36
- Movantik (Drug) $536.57
- Victoza (Drug) $532.18
- NURTEC ODT (Drug) $511.54
- Aimovig (Biological) $492.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Carbondale
Dr. Neal Davis, Do, DO
Family Medicine — Payments: $6,619
Dr. David Penn, M.d, M.D
Family Medicine — Payments: $3,972
Dr. Terry Luma, M.d, M.D
Family Medicine — Payments: $3,637
Mr. Roger Jones, Md, MD
Family Medicine — Payments: $3,460
Dr. Neda Danniel, Md, MD
Family Medicine — Payments: $3,413
Dr. Ana Migone, M.d, M.D
Family Medicine — Payments: $3,378